2Husemann Y, Geigl J B, Schubert F, et al. Systemic spread is an early step in breast cancer[J].Cancer Cell, 2008, 13(1) :58-68.
3Cristofanilli M, Budd G T, Ellis, M J, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer[J].N EnglJ Med, 2004, 351(8): 781-791.
5Meng S, Tripathy D, Shete S, et al. HER 2 gene amplification can be acquired as breast cancer progresses[J]. Proc Natl Acad Sci U S A, 2004,101(25)9393-9398.
二级参考文献19
1Citron M L,Berry D A,Cirrincione C et al.Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 974[J].J Clin Oncol,2003,21 (8):1431-1439.
2Hong L,Hunt M,Chui C,et al.Intensity-modulated tangential beam irradiation of the intact breast[J].Int J Radiat Oncol Biol Phys,1999,44(5):1155-1164.
3Vaidya JS,Baum M,Tobias JS,et al.The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer[J].Eur J Surg Oncol,2002,28 (4):447-454.
4Orecchia R,Ciocca M,Tosi G,et al.Intraoperative electron beam radiotherapy (ELIOT) to the breast:a need for a quality assurance programme[J].Breast,2005,14(6):541 -546.
5van' t Veer LJ,Dai H,van de Vijver MJ,et al.Gene expression profiling predicts clinical outcome of breast cancer[J].Nature,2002,415 (6871):530-536.
6Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006 [J]. CA Cancer J Clin, 2006, 56(2): 106-130.
7Cristofanilli M, Budd GT, Ellis M J, et al.Circulating tumor cells, disease progression, and survival in metastatic breast cancer[J]. N Engl J Med, 2004, 351(8):781-791.
8Mocellin S, Keilholz U, Rossi CR, et al. Circulating tumor cells: the 'leukemic phase' of solid cancers[J]. Trends Mol Med, 2006, 12(3): 130-139.
9Liu Z,Jiang M,Zhao J, et al. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility [J]. Clin Cancer Res, 2007, 13(10):2992-2997.
10Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that cireulating epithelial cells in patients with carcinoma are malignant[J]. Clin Cancer Res, 2002, 8(7):2073-2084.
1Gennari A, Stockler M, Puntoni M, et al. Duration of chemo- therapy for metastatic breast cancer:a systematic review and me ta-analysis of randomized clinical trialsEJ3. J Clin Oncol, 2011, 29(16) :2144 2149,.
2Swaby RF, Cristofanilli M. Circulating tumor cells in breast cancer: a tool whose time has come of ageEJ3. BMC Meal, 2011,9.-43.
3Lianidou ES, Strati A, Markou A. Circulating tumor ceils as promising novel biomarkers in solid cancersEJ3. Crit Rev Clin Lab Sci, 2014, 51(3) ~160-171.
4Riahi R, Gogoi P, Sepehri S, et al. A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer~J3. Int J Oncol, 2014, 44(6) =1870-1878.
5Breitenbuecher F, Hoffarth S, Worm K, et al. Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancerpatientsFJ~. PloSOne, 2014, 9(1):e85350.
6Lou J, Ben S, Yang G, et al. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand targeted PCR[J]. PloSOne, 2013, 8(12):e80458.
7Steinert G, Seholch S, Niemietz T, et al. Immune escape and survival mechanisms in circulating tumor cells of colorectal canc- er[J]. CancerRes, 2014,74(6):1694-1704.
8Groot Koerkamp B, Rahhari NN, guchler MW, et al. Circulat ing tumor cells and prognosis of patients with resectable colorec tal liver metastases or widespread metastatic eolorectal cancer: a meta-analysis[J]. Ann Surg OncoI, 2013,20(7)~2156 2165.
9Tjensvoll K, Nordgard O, Smaaland R. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications[J]. Int J Cancer, 2014,134(1) : 1-8.
10Cen P, Ni X, Yang J, et al. Circulating tumor cells in the diag- nosis and management of pancreatic cancer[J]. Biochim Biophys Acta, 2012,I826(2) :350-356.
